GP 1 Tablet contains Glimepiride 1mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby lowering blood glucose levels. GP 1 Tablet is typically prescribed as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes cannot be adequately managed by lifestyle modifications alone. The medication is effective in reducing both fasting and postprandial blood glucose concentrations. It is important to initiate therapy at the lowest effective dose to minimize the risk of hypoglycemia, with dose adjustments based on patient response and glycemic targets. Common adverse effects include hypoglycemia, weight gain, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it should be used with care in elderly patients due to increased susceptibility to hypoglycemia. GP 1 Tablet is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Regular monitoring of blood glucose and periodic assessment of renal and hepatic function are recommended during therapy. Patient education on recognizing and managing hypoglycemia is essential for safe and effective use of this medication.

Dosage & How to Use